Zubkova T.G., Pozdnyakova M.G., Agafyina A.S., Rodygin S.A., Popova I.A.
Efficacy oF «Galavit®» in combination therapy of ari аnd influenza in adult patients: results of a multicenter randomized double-blind placebo-controlled study
|
№4 / 2024
|
Mamoshina M.V., Yatsyshina S.B., Akimkin V.G.
Analysis of the results of monitoring the pathogens of acute respiratory viral infection, influenza, and COVID-19 in asymptomatic individuals
|
№2 / 2023
|
Ponezheva Zh.B., Ponezheva L.O., Kupchenko A.N., Gultyaev M.M.
Clinical efficacy of umifenovir in acute respiratory viral infections
|
№5 / 2017
|
Ruzhentsova T.A.
Cardiovascular disorders in children with influenza and other acute respiratory viral infections
|
№5 / 2017
|
Kupchenko A.N., Ponezheva Z.B., Romeyko V.B.
Clinical efficacy of standard antiviral drugs in the treatment of ARVI patients with complications
|
№6 / 2016
|
Mikhaylova E.V., Chudakova T.K., Danilov A.N.
The clinical features of acute respiratory viral infections and the improvement of therapy in a group of frequently ill children
|
№3 / 2014
|
Feklisova L.V.
Clinical and laboratory evaluation of interferon preparations used in children with acute respiratory diseases in therapeutic and health-improving institutions
|
№1 / 2012
|
Shuldyakov A.A., Lyapina E.P.
Some aspects of current etiotropic therapy for influenza and acute respiratory viral infections
|
№2 / 2011
|